Teriparatide (rhPTH [1-34]) treatment improves the structure of the proximal femur in women with osteoporosis.

被引：0
|
作者：
Semanick, LM
Uusi-Rasi, K
Zanchetta, JR
Bogado, CE
Eriksen, EF
Sato, M
Beck, TJ
机构：
[1] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA
[2] IDIM & USAL Univ, Buenos Aires, DF, Argentina
[3] Johns Hopkins Univ, Sch Med, Dept Radiol, Baltimore, MD 21205 USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2003年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S40 / S40
页数：1
相关论文
共 50 条
  • [1] TERIPARATIDE (RHPTH [1-34]) TREATMENT IMPROVES THE STRUCTURE OF THE PROXIMAL FEMUR IN WOMEN WITH OSTEOPOROSIS: RESULTS FROM THE FRACTURE PREVENTION TRIAL
    Scmanick, L. M.
    Uusi-Rasi, K.
    Zanchetta, J. R.
    Bogado, C. E.
    Eriksen, E. F.
    Sato, M.
    Beck, T. J.
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2004, 74 : S37 - S37
  • [2] Effects of teriparatide [rhPTH (1-34)] treatment on structural geometry of the proximal femur in elderly osteoporotic women
    Uusi-Rasi, K
    Semanick, LM
    Zanchetta, JR
    Bogado, CE
    Eriksen, EF
    Sato, M
    Beck, TJ
    [J]. BONE, 2005, 36 (06) : 948 - 958
  • [3] Pharmacokinetics of Teriparatide (rhPTH[1-34]) and Calcium Pharmacodynamics in Postmenopausal Women with Osteoporosis
    Satterwhite, Julie
    Heathman, Michael
    Miller, Paul D.
    Marin, Fernando
    Glass, Emmett V.
    Dobnig, Harald
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2010, 87 (06) : 485 - 492
  • [4] Teriparatide [RHPTH (1-34)] treatment reduces the incidence of back pain in postmenopausal women with osteoporosis
    Krege, JH
    Xie, L
    Genant, HK
    [J]. OSTEOPOROSIS INTERNATIONAL, 2003, 14 : S75 - S75
  • [5] Teriparatide (rhPTH(1-34) improves the structural geometry of the hip
    Uusi-Rasi, K
    Beck, TJ
    Oreskovic, TL
    Sato, M
    Boado, CE
    Zanchetta, JR
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 : S208 - S208
  • [6] Teriparatide -: rhPTH(1-34) -: LY-333334 -: Forteo® -: Treatment of osteoporosis -: Parathyroid hormone
    不详
    [J]. DRUGS OF THE FUTURE, 2001, 26 (08) : 824 - 827
  • [7] Endogenous intact PTH is suppressed during teriparatide (rhPTH 1-34) administration in postmenopausal women with established osteoporosis
    Anastasilakis, Athanasios D.
    Polyzos, Stergios A.
    Goulis, Dimitrios G.
    Slavakis, Aristides
    Efstathiadou, Zoe
    Kita, Marina
    Koukoulis, George
    Avramidis, Avraam
    [J]. ENDOCRINE JOURNAL, 2008, 55 (03) : 613 - 616
  • [8] Effects of Intravenous Zoledronic Acid Plus Subcutaneous Teriparatide [rhPTH(1-34)] in Postmenopausal Osteoporosis
    Cosman, Felicia
    Eriksen, Erik Fink
    Recknor, Chris
    Miller, Paul D.
    Guanabens, Nuria
    Kasperk, Christian
    Papanastasiou, Philemon
    Readie, Aimee
    Rao, Hanumantha
    Gasser, Juerg A.
    Bucci-Rechtweg, Christina
    Boonen, Steven
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2011, 26 (03) : 503 - 511
  • [9] Pharmacokinetics of Teriparatide (rhPTH[1–34]) and Calcium Pharmacodynamics in Postmenopausal Women with Osteoporosis
    Julie Satterwhite
    Michael Heathman
    Paul D. Miller
    Fernando Marín
    Emmett V. Glass
    Harald Dobnig
    [J]. Calcified Tissue International, 2010, 87 : 485 - 492
  • [10] Distinctive effects of teriparatide [rhPTH(1-34)] and alendronate on bone turnover and lumbar spine bone density in women with osteoporosis
    McClung, MR
    Miller, PD
    Civitelli, R
    Warren, ML
    Greenspan, SL
    Tamayo, JA
    Donley, DW
    San Martin, J
    [J]. OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S18 - S18
12345